Internal Medicine, Hematology · Stanford, CA
NPI
1750389250
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
322 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Hyma T Vempaty prescribed most often to Medicare patients was Hydroxyurea, with 36 prescriptions and refills. In total Hyma T Vempaty wrote 322 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxyurea Generic | 36 | 110 | 15 | $1,686 |
| Lenalidomide Generic | 28 | 28 | Under 11 | $270K |
| Acyclovir Generic | 27 | 69 | 11 | $720 |
| Jakafi Ruxolitinib Phosphate | 23 | 23 | Under 11 | $198K |
| Prednisone Generic | 22 | 33 | Under 11 | $229 |
| Dexamethasone Generic | 19 | 48 | Under 11 | $466 |
| Brukinsa Zanubrutinib | 14 | 14 | Under 11 | $89K |
| Alvaiz Eltrombopag Choline | 13 | 13 | Under 11 | $82K |
| Pomalyst Pomalidomide | 11 | 11 | Under 11 | $261K |
Brand drugs: 100 claims; generic drugs: 222 claims; opioid claims: 11.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Hyma T Vempaty were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.